- Report
- December 2023
- 120 Pages
Global
From €5302EUR$5,950USD£4,600GBP
- Report
- January 2023
- 217 Pages
Global
From €5302EUR$5,950USD£4,600GBP
- Report
- May 2021
- 250 Pages
Global
From €5302EUR$5,950USD£4,600GBP
- Report
- February 2023
- 200 Pages
Global
From €5302EUR$5,950USD£4,600GBP
- Report
- February 2023
- 265 Pages
Global
From €5302EUR$5,950USD£4,600GBP
- Report
- May 2022
- 61 Pages
Global
- Report
- April 2023
- 501 Pages
Global
From €4456EUR$5,000USD£3,865GBP
- Report
- April 2023
- 200 Pages
Global
From €4456EUR$5,000USD£3,865GBP
- Report
- February 2023
- 175 Pages
Global
From €4456EUR$5,000USD£3,865GBP
- Drug Pipelines
- November 2020
- 78 Pages
Global
From €3119EUR$3,500USD£2,706GBP
- Drug Pipelines
- July 2020
- 33 Pages
Global
From €3119EUR$3,500USD£2,706GBP
- Drug Pipelines
- February 2020
- 96 Pages
Global
From €3119EUR$3,500USD£2,706GBP
- Drug Pipelines
- January 2020
- 112 Pages
Global
From €3119EUR$3,500USD£2,706GBP
- Report
- June 2021
Global
From €3564EUR$4,000USD£3,092GBP
- Report
- May 2023
- 294 Pages
Global
From €4456EUR$5,000USD£3,865GBP
- Report
- December 2024
- 87 Pages
Spain
From €2651EUR$2,975USD£2,300GBP
€3119EUR$3,500USD£2,706GBP
- Report
- July 2024
- 80 Pages
Japan
From €2651EUR$2,975USD£2,300GBP
€3119EUR$3,500USD£2,706GBP
- Report
- May 2024
- 182 Pages
Global
From €3408EUR$3,825USD£2,957GBP
€4010EUR$4,500USD£3,479GBP
- Report
- May 2024
- 184 Pages
Global
From €3408EUR$3,825USD£2,957GBP
€4010EUR$4,500USD£3,479GBP
- Report
- May 2024
- 185 Pages
Global
From €3408EUR$3,825USD£2,957GBP
€4010EUR$4,500USD£3,479GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more